5 Stocks Under $5 That Will Explode

2. Neumora Therapeutics, Inc. (NASDAQ:NMRA)

Neumora Therapeutics, Inc. (NASDAQ:NMRA) is featured in our list of the best penny stocks set to explode.

As of April 8, 2026, analyst sentiment toward Neumora Therapeutics, Inc. (NASDAQ:NMRA) remains bullish, with 78% of analysts assigning a “Buy” rating to the stock. The consensus price target of $8 implies a potential upside of 275.59%.

Reinforcing this constructive sentiment, on March 31, 2026, Guggenheim reiterated its “Buy” rating with a $14 price target on the stock. This development followed the company’s fourth-quarter 2025 results and pipeline update.

On March 30, 2026, Neumora Therapeutics, Inc. (NASDAQ:NMRA) highlighted significant progress in a number of programs, including the completion of enrollment in two late-stage navacaprant studies, which are expected to yield results in Q2 2026, and the receipt of positive early clinical signals for NMRA-898 in schizophrenia. Additionally, the company reported encouraging Phase 1b data for NMRA-511 in Alzheimer’s disease agitation.

Moreover, the company provided investors with an update on NMRA-215 in obesity, where positive preclinical evidence was counterbalanced by unexpected toxicological findings that are currently being reevaluated. Neumora Therapeutics, Inc. (NASDAQ:NMRA) reported that it had $182.5 million in cash at the end of 2025, with the company’s runway expected to extend until Q3 2027. This capital will be used to support multiple near-term pipeline catalysts.

Neumora Therapeutics, Inc. (NASDAQ:NMRA) is a clinical-stage biopharmaceutical company that specializes in developing targeted therapies for complex neuropsychiatric and neurodegenerative conditions. These range from major depressive disorder to Alzheimer’s and Parkinson’s. By focusing on the science of the central nervous system, they aim to provide life-changing solutions for those facing mental health and neurological challenges.